Summary: New research from Arizona State University finds that young adults with obesity already show biological signs linked to liver stress, chronic inflammation, and early neuronal injury—changes commonly observed in older adults with cognitive impairment. The study also found unusually low circulating choline, a nutrient essential for liver function, inflammation control, and long-term brain health. Low choline strongly correlated with higher neurofilament light chain (NfL), an early marker of neuronal damage, suggesting that metabolic stress and nutrient insufficiency may begin shaping the biology of brain aging much earlier than previously recognized.
These results highlight a potential metabolic-to-brain pathway in which obesity, insulin resistance, and inadequate nutrient status interact to produce measurable markers of neural stress decades before clinical cognitive symptoms would typically appear.
Key Facts:
- Low choline association: Young adults with obesity had significantly lower blood choline levels, which correlated with systemic inflammation, liver enzyme elevations, insulin resistance, and higher NfL.
- Early neuronal stress: Elevated neurofilament light chain in these participants indicates neuron injury well before expected cognitive decline.
- Metabolic-brain connection: The study supports a linked pathway among metabolic dysfunction, inflammation, nutrient deficiency, and early neuronal injury that could increase long-term dementia risk.
Source: Arizona State University
Background
Decades of research show that conditions that damage the body—such as obesity, hypertension, and insulin resistance—also harm the brain. These systemic stressors accelerate vascular and metabolic dysfunction, which over time increases the likelihood of cognitive decline and Alzheimer’s disease. The new ASU-led study suggests these damaging biological processes may begin much earlier in life than currently appreciated.
Early markers linking obesity to brain health
While obesity is a well-established risk factor for cardiovascular disease and type 2 diabetes, this study demonstrates that obesity-related metabolic disturbances are associated with early indicators of brain health disruption in young adults. Researchers measured inflammatory cytokines, liver-related enzymes, insulin resistance markers, circulating choline, and neurofilament light chain (NfL) in a cohort of young adults and found a consistent pattern: higher inflammation and liver stress, reduced choline, and increased NfL in participants with obesity.
NfL is increasingly used as a sensitive biomarker of neuronal injury and neurodegeneration; it is typically elevated in mild cognitive impairment and Alzheimer’s disease. Detecting higher NfL in young adults with obesity—paired with low choline and metabolic dysfunction—suggests that obesity can leave early, measurable footprints on neuronal integrity long before clinical symptoms emerge.
A nutrient at the center of the puzzle
Choline is an essential nutrient involved in liver function, cell-membrane integrity, methylation reactions, and the production of the neurotransmitter acetylcholine. In this study, participants with obesity showed markedly lower circulating choline, and those low levels correlated with higher inflammation, insulin resistance, liver enzyme elevations, and greater NfL concentrations.
Choline is produced in limited amounts by the liver and primarily obtained from dietary sources such as eggs, fish, poultry, beans, and cruciferous vegetables. National dietary surveys indicate many people—especially adolescents and young adults—consume less than recommended choline, which could leave them more vulnerable to metabolic stress and its downstream effects on the brain. The researchers also observed lower choline levels in women compared with men, a notable point given the greater burden of cognitive decline and Alzheimer’s disease in women.
Study co-authors emphasize that raising awareness of dietary choline intake and considering choline-rich choices or supplementation where appropriate may support liver and brain resilience across the lifespan.
Nutritional risks with modern weight-loss therapies
New GLP-1-based weight-loss medications have greatly changed obesity management by reducing appetite and caloric intake. However, these drugs can alter dietary patterns, and individuals taking them may inadvertently reduce consumption of choline and other key nutrients. The authors suggest future research should evaluate whether pairing GLP-1 therapies with adequate choline intake or supplementation can protect metabolic and neuronal health during weight-loss treatment.
How the study was conducted
The cross-sectional study included 30 young adults in their 20s and 30s: half with obesity (BMI > 30) and half with healthy BMI (18.5–24.9). Each participant provided a fasting blood sample for measurement of circulating choline, inflammatory cytokines, insulin, glucose, liver-related enzymes, and neurofilament light chain (NfL). Comparing these biomarkers between groups revealed a clear association linking obesity to lower choline, higher inflammation and insulin resistance, liver dysfunction markers, and elevated NfL.
To explore the broader relevance of these findings, researchers compared the choline–NfL relationship from the young-adult cohort with data from older adults diagnosed with mild cognitive impairment or Alzheimer’s disease. The same pattern—lower circulating choline accompanying higher NfL—was observed in those older clinical cohorts, supporting the idea that related biological pathways may begin decades before clinical cognitive decline.
Although the study is observational and does not prove causation, the biomarker constellation it identifies mirrors patterns seen in neurodegenerative disease and suggests potential early intervention targets to preserve brain health.
Key Questions Answered:
A: Elevated systemic inflammation, liver stress markers, reduced circulating choline, and early signs of neuronal damage as indicated by higher neurofilament light chain (NfL).
A: Low blood choline is strongly associated with inflammation, metabolic dysfunction, liver stress, and increased NfL—linking nutrient status to early neuronal injury risk.
A: The study suggests that obesity may activate biological pathways associated with later-life cognitive impairment decades before symptoms appear, highlighting an opportunity for earlier monitoring and intervention.
Editorial Notes:
- This article was edited by a Neuroscience News editor.
- The journal paper was reviewed in full.
- Additional context was added by editorial staff.
About this obesity and brain health research news
Author: Sandy Leander
Source: Arizona State University
Contact: Sandy Leander, Arizona State University
Image: The image is credited to Neuroscience News
Original Research: Reduced circulating choline in young adults with obesity is associated with metabolic dysfunction, inflammation, and elevated neurofilament light chain—factors linked to mild cognitive impairment and Alzheimer’s disease. The study appears in the journal Aging and Disease.
Abstract
Reduced Circulating Choline in Young Adults with Obesity Is Associated with Metabolic Dysfunction, Inflammation, and Elevated Neurofilament Light Chain—Factors Linked to Mild Cognitive Impairment and Alzheimer’s Disease
Abstract
Rising obesity rates raise significant concerns for aging and brain health because insulin resistance—common in both obesity and Alzheimer’s disease—can accelerate neurodegeneration. Adequate choline intake may reduce the risk of obesity and insulin resistance, yet many people consume less than recommended levels, a shortfall associated with increased Alzheimer’s risk.
This cross-sectional study measured circulating choline, metabolic markers, inflammatory cytokines, and neurofilament light (NfL) in young adults (mean age 33.6 years) with obesity (BMI > 30) and in healthy-weight controls (BMI 18.5–24.9). The researchers also examined whether circulating choline correlated with NfL in separate cohorts of older adults diagnosed with mild cognitive impairment or Alzheimer’s disease.
Obese participants showed reduced circulating choline, which correlated with higher body fat percentage, liver dysfunction markers, increased insulin resistance, and elevated inflammatory cytokines. NfL levels were higher in obese participants and inversely correlated with circulating choline—a pattern also seen in the clinical MCI and AD cohorts. These findings reveal associations among obesity, low choline, insulin resistance, systemic inflammation, and NfL—biomarkers linked to Alzheimer’s disease risk. Monitoring these markers in early adulthood could help assess future cognitive risk in individuals prone to obesity and metabolic dysfunction.